Natural killer (NK) cell-mediated antibody-dependent cellular cytotoxicity (ADCC), based on the recognition of IgG-opsonized targets by the low-affinity receptor for IgG FcγRIIIA/CD16, represents one of the main mechanisms by which therapeutic antibodies (mAbs) mediate their antitumor effects. Besides ADCC, CD16 ligation also results in cytokine production, in particular, NK-derived IFNγ is endowed with a well-recognized role in the shaping of adaptive immune responses. Obinutuzumab is a glycoengineered anti-CD20 mAb with a modified crystallizable fragment (Fc) domain designed to increase the affinity for CD16 and consequently the killing of mAb-opsonized targets. However, the impact of CD16 ligation in optimized affinity conditions on NK functional program is not completely understood. Herein, we demonstrate that the interaction of NK cells with obinutuzumab-opsonized cells results in enhanced IFNγ production as compared with parental non-glycoengineered mAb or the reference molecule rituximab. We observed that affinity ligation conditions strictly correlate with the ability to induce CD16 down-modulation and lysosomal targeting of receptor-associated signaling elements. Indeed, a preferential degradation of FcεRIγ chain and Syk kinase was observed upon obinutuzumab stimulation independently from CD16-V158F polymorphism. Although the downregulation of FcεRIγ/Syk module leads to the impairment of cytotoxic function induced by NKp46 and NKp30 receptors, obinutuzumab-experienced cells exhibit an increased ability to produce IFNγ in response to different stimuli. These data highlight a relationship between CD16 aggregation conditions and the ability to promote a degradative pathway of CD16-coupled signaling elements associated to the shift of NK functional program

Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production / Capuano, Cristina; Pighi, Chiara; Molfetta, Rosa; Paolini, Rossella; Battella, Simone; Palmieri, Gabriella; Giannini, Giuseppe; Belardinilli, Francesca; Santoni, Angela; Galandrini, Ricciarda. - In: ONCOIMMUNOLOGY. - ISSN 2162-402X. - STAMPA. - 6:3(2017), p. e1290037. [10.1080/2162402X.2017.1290037]

Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production

CAPUANO, CRISTINA;PIGHI, CHIARA;MOLFETTA, Rosa;PAOLINI, Rossella;BATTELLA, SIMONE;PALMIERI, Gabriella;GIANNINI, Giuseppe;BELARDINILLI, FRANCESCA;SANTONI, Angela;GALANDRINI, Ricciarda
2017

Abstract

Natural killer (NK) cell-mediated antibody-dependent cellular cytotoxicity (ADCC), based on the recognition of IgG-opsonized targets by the low-affinity receptor for IgG FcγRIIIA/CD16, represents one of the main mechanisms by which therapeutic antibodies (mAbs) mediate their antitumor effects. Besides ADCC, CD16 ligation also results in cytokine production, in particular, NK-derived IFNγ is endowed with a well-recognized role in the shaping of adaptive immune responses. Obinutuzumab is a glycoengineered anti-CD20 mAb with a modified crystallizable fragment (Fc) domain designed to increase the affinity for CD16 and consequently the killing of mAb-opsonized targets. However, the impact of CD16 ligation in optimized affinity conditions on NK functional program is not completely understood. Herein, we demonstrate that the interaction of NK cells with obinutuzumab-opsonized cells results in enhanced IFNγ production as compared with parental non-glycoengineered mAb or the reference molecule rituximab. We observed that affinity ligation conditions strictly correlate with the ability to induce CD16 down-modulation and lysosomal targeting of receptor-associated signaling elements. Indeed, a preferential degradation of FcεRIγ chain and Syk kinase was observed upon obinutuzumab stimulation independently from CD16-V158F polymorphism. Although the downregulation of FcεRIγ/Syk module leads to the impairment of cytotoxic function induced by NKp46 and NKp30 receptors, obinutuzumab-experienced cells exhibit an increased ability to produce IFNγ in response to different stimuli. These data highlight a relationship between CD16 aggregation conditions and the ability to promote a degradative pathway of CD16-coupled signaling elements associated to the shift of NK functional program
2017
ADCC; Fc glycoengineering; FcγRIIIA/CD16; IFNγ; NK cells; obinutuzumab; Immunology and Allergy; Immunology; Oncology
01 Pubblicazione su rivista::01a Articolo in rivista
Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production / Capuano, Cristina; Pighi, Chiara; Molfetta, Rosa; Paolini, Rossella; Battella, Simone; Palmieri, Gabriella; Giannini, Giuseppe; Belardinilli, Francesca; Santoni, Angela; Galandrini, Ricciarda. - In: ONCOIMMUNOLOGY. - ISSN 2162-402X. - STAMPA. - 6:3(2017), p. e1290037. [10.1080/2162402X.2017.1290037]
File allegati a questo prodotto
File Dimensione Formato  
Capuano_Obinutuzumab-mediated_2017.pdf

accesso aperto

Note: post-print
Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.77 MB
Formato Adobe PDF
1.77 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/951356
Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 37
social impact